Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB9AP5 is a genomic sequence classified as a pseudogene related to the RAB9A (RAB9A, member RAS oncogene family) gene. Pseudogenes do not produce functional proteins and are not known to play an active role in normal biological processes or disease. In contrast, the protein-coding gene RAB9A encodes Ras-related protein Rab-9A, a small GTPase belonging to the Rab family involved in endosomal trafficking and membrane transport[2][4][8]. The term "RAB9AP5" is not associated with a recognized therapeutic target, receptor, transporter, or enzyme, and has no documented biological function, disease association, or interaction with drugs. Any mention of "RAB9AP5" or its aliases should be clarified as referring to a pseudogene, not an active protein-coding gene or drug target[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB9A, member RAS oncogene family pseudogene 5 (RAB9AP5).